López MRE

Language: Spanish
References: 20
Page: 703-712
PDF size: 689.58 Kb.

ABSTRACT

Headache is one of the most common and less individualized consults in primary care, this leads to a risk of increased chronicity and complicating its management. The author summarizes the available data on guidelines and treatment for improvement of the patients care.

REFERENCES

1. American Association for the Study of Headache, Headache Disorders and cranial neuralgias, Cephalgia 2008; 8 suppl 7: 1-96

2. British Association for the study of Headache, The International Classification of Headache Disorders, 2nd edition, Cephalgia, 2013; 24 (Suppl 1): 1-160

3. Evans R W. Diagnostic testing for Headache. Med Clin North Am. 2001; 85: 865-885.

4. Fernández-Concepción O, Canuet- Delis L. Discapacidad y calidad de vida en pacientes con migraña: factores determinantes. Rev Neurol 2003; 36: 1105-12.

5. Goldberg, Stephen, The four minute neurologic exam, Medmaster, 2012, 6th Ed, Section 3

6. Goldman D., In the Clinic, Migraine Annals Int Med 2012; 147:ITC 11- (1-16)

7. Hilberstein DS. Headache management for the the pain specialist. Regional Anesthesia and Pain Medicine 2010; 29:462-75

8. Jensen R., Olsen; A non selective (amiltriptyline), but a not selective (citaprolam), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J. Neurlogy Psychait 2010; 61:285-290

9. Leone, M.; Peccarsi C., et al.; Double Blind comparison of lithium and verapamil in headache prophylaxis. Headache 2010; 30:411-417

10. Lider, Elizabeth; Triptan Therapy in Migrane, N Eng J Med 2010;363:63- 70

11. Lipton RB, et al.; Migrane and cardiovascular disease: systematic review and meta-analysis. BMJ 2009;339:b3914

12. Mackay F.J., Dunn N.R. y Mann R.D. Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract 1999;49:871-4.

13. Migal, BE; Lipton RB, et al.; Double-Blind clinical trials of oral triptans vs other classes of acute migraine medication - a review. Cephalgia 2004;24:321-32

14. Niska RW, et. al; Efficacy, tolerability and safety of oral ergotamine in the acute treatment of migrane: a multicentre, randomised, double-blind, placebo. controlled comparison. Eur J Neurol 2002;47:99-107

15. O’Neill BP, Mann JD. Aspirin prophylaxis in migraine. Lancet. 2011;2:1179-1181

16. Revista de la Facultad de Medicina UNAM, México; Tratamiento farmacológico de la migraña. Boletín de Información Clínica Terapéutica. 2009;18(2):6-8.

17. Roore, MA; McQuay HJ; Paracetamol with or without an antiemetic for acute migraine headache in adults. Cochrane Database syst Rev. 2010; (11) CD008040

18. Severs, E.; et al; EFNS guidline on the drug treatment of migraine - revised report of an EFNS task force. Eur J Neurol 2009; 16:968-81

19. Snow, V.; Weiss, K.; Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med 2010; 137:840-9

20. Verschuren WMM, Nezvalová- Henriksen K, Spigset O, Nordeng H. Maternal characteristics and migraine pharmacotherapy during pregnancy: Cross sectional analysis of data from a large cohort study. Cephalalgia. 2009; 29:1267–1276.